Delays Medicare price talks for some prescription drugs by four years.
This bill would change the rules for Medicare's drug price negotiation program. It would give drug companies an extra four years before Medicare could negotiate prices for certain types of prescription drugs, called small-molecule drugs. This change would start in 2028, potentially delaying lower prices for Medicare beneficiaries.
Today, Medicare can negotiate prices for small-molecule drugs after at least 7 years and for biologic drugs after at least 11 years. If this bill becomes law, small-molecule drugs would also get at least 11 years before Medicare could negotiate their prices, starting in 2028. The 7-year period would still apply for 2026 and 2027.
S 832 · 119th Congress · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
51 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.